PPIDT00337
Drug Information
| Name | Aducanumab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB12274 |
| Type | biotech |
| Indication | Aducanumab is indicated for the treatment of Alzheimer’s disease. Treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. There are no safety or effectiveness data on initiating treatment at earlier or later stages of the disease than were studied.[L45146] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravenous |
100 mg/1mL
|